Fact based stock research
Biotest (DB:BIO3)


Biotest stock research in summary

biotest.de


Biotest stock research analysis by the purely financial fact-based Obermatt method on current and historical performance by investment strategy | Biotest (DB:BIO3), Biotechnology, Germany


Latest Obermatt Ranks


Country Germany
Industry Biotechnology
Index CDAX, SDAX
Size class Small

January 19, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Gold Winner CEO

Top 10 Stock






 

Research History: Biotest

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
59
46
37
37
STOCK GROWTH RANKS
6
52
55
STOCK SAFETY RANKS
39
20
71
71
COMBINED STOCK RANKS
65
25
13
13

Last update of Combined Rank: 7-Apr-2017. Stock research history is based on the Obermatt Method. The higher the rank, the better is Biotest in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2015 2016 2017 2018
PRICE VS. REVENUES (P/S)
83
74
59
59
PRICE VS. PROFITS (P/E)
60
15
3
3
PRICE VS. CAPITAL (Market-to-Book)
62
65
78
78
DIVIDEND YIELD
45
33
32
32
CONSOLIDATED RANK: VALUE
59
46
37
37

Last update of Value Rank: 19-Jan-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Biotest; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
20
52
53
PROFIT GROWTH
3
97
82
STOCK RETURNS
3
4
94
CONSOLIDATED RANK: GROWTH
6
52
55

Financial reporting date of Growth Rank: 30-Sep-2016. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Biotest.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
15
20
16
16
REFINANCING
78
78
LIQUIDITY
73
47
76
76
CONSOLIDATED RANK: SAFETY
39
20
71
71

Financial reporting date of Safety Rank: 1-Jan-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Biotest and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Biotest from January 19, 2018.